米国市場銘柄情報

DMTK ダームテック

銘柄追加

0.610
-0.019-3.07%

取引中 05/03 15:44 ET

2,133.09万時価総額-197直近PER

ダームテックに関するコメント

ログインコメントを投稿

Moomoo AI

02/01 21:25

DermTech's low P/S ratio is likely due to limited future growth expectations. Poor revenue performance and a lower-than-industry growth forecast have reduced investor willingness to pay more for the stock. A significant change in fortune is needed for a higher P/S ratio.

DermTech, Inc. (NASDAQ:DMTK) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough

Trytosaveabit

02/01 05:44

Update

$ダームテック(DMTK.US)$ DermTech Announces Restructuring Actions And Emphasis On Growing Revenue For DermTech Melanoma Test ; Co. To Reduce 15% Of Workforce, Expects ~$40M In Total Operating Expense Reductions

Trytosaveabit

01/18 21:14

Update

$ダームテック(DMTK.US)$ DermTech Announces Topline Results From Study Evaluating DermTech Melanoma Test Across All Skin Types; Negative Predictive Value Higher Than 99% Regardless Of Skin Type

AmyNic

2023/11/03 05:03

ok 👀 👀

$ダームテック(DMTK.US)$

Sam Wallstreet

2023/01/14 00:04

QUICK SCALP 5 $DMTK — STOCK & OPTION PLAY
ALERT ON: $5.08
ON THE WATCH: $5.15
🥇 SIGNED OF MORE UPTREND: $5.23
NEED IT TO BREAK OVER: $5.37
key indicator for MORE uptrend $5.52
confirmation uptrend - $5.73
mini breakout - $5.95. $ダームテック(DMTK.US)$

GAME_DAY

2023/01/11 07:34

AH+1/11 Watchlist

follow for nightly watchlist ⚡️
$アッヴィ(ABBV.US)$$ブロードコム(AVGO.US)$$バイオアトラ(BCAB.US)$$ビオラ・セラピューティクス(BIOR.US)$$ダームテック(DMTK.US)$ $ブロードウィンド(BWEN.US)$$キュアバック(CVAC.US)$$EVゴー(EVGO.US)$$ヘピオン・ファ―マシュ―ティカルズ(HEPA.US)$$AMTDデジタル(HKD.US)$$イコル・ホールディングス(ICHR.US)$$マスターカード(MA.US)$$ネクストプレイ・テクノロジーズ(NXTP.US)$$Party City Holdco(PRTY.US)$$スターバックス(SBUX.US)$

Moomoo Breakfast US

2022/05/19 20:15

コラムToday's pre-market stock movers: GOOS, TSLA, KSS, UAA and more

Gainers:
• $ロケット・ファーマシューティカルズ(RCKT.US)$ +10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy)
• $カナダ・グース・ホールディングス(GOOS.US)$ +9.4% (the company reported an unexpected profit as well as better-than-expected revenue)
• $シガテクノロジーズ(SIGA.US)$ +6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...